STUDI PENGGUNAAN FUROSEMIDE PADA PASIEN GAGAL JANTUNG (Penelitian Dilakukan di RSI Aisyiyah Malang)

Background: Heart failure is a major issue in cardiovascular disease, characterized by the inability of the heart to pump blood effectively. The primary causes include chronic hypertension, myocardial infarction, and structural heart disorders. Fluid retention leads to pulmonary congestion, peripheral edema, and metabolic disturbances, making pharmacological therapy essential for management. One of the key treatments is the use of diuretics such as furosemide to reduce fluid retention and alleviate shortness of breath in patients.
Objective: This study aims to observe and describe the patterns of furosemide use in heart failure patients at RSI Aisyiyah Malang, covering type, dosage, administration route, frequency, and duration of use.
Methode: This research was conducted using an observational and descriptive approach, with retrospective data collection from patient medical records. Analysis was performed to understand the furosemide therapy patterns and their correlation with clinical and laboratory parameters.
Result and Conclusions: The use of furosemide in heart failure patients at RSI Aisyiyah Malang was not administered as a single therapy but in combinations. The most common two-drug combination was furosemide (3×40 mg) iv + bisoprolol (1×2.5 mg) po, used in 7 patients (14%). The most frequent three-drug combination was furosemide (3×40 mg) iv + spironolactone (1×25 mg) po + bisoprolol (1×2.5 mg) po, used in 18 patients (19%). Switch patterns were observed in 42 patients, with five main switching patterns identified.